Live Quote · AMEXAPUSHealthcare· Biotechnology

Apimeds Pharmaceuticals US, Inc

$1.60▼ 8.05%($-0.14)
MKT CAP $2.41MLAST EARNINGS Nov 11, 2026
50%
Bullish
TickerSpark Score
43/100
▌ Weak
80
Valuation
40
Profitability
15
Growth
52
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a APUS research report →

Price Chart

-94.26% · this period
$30.30$15.95$1.60Nov 19May 22Nov 19
52-Week Range0% of range
Low
$1.51
Current
$1.60
High
$59.70